Abstract
Groups of younger and aged mice were fed either minimal basal diet or the same diet containing 40 ppm melatonin. After 9.3 weeks half of each of these 4 groups of animals received either an intraperitoneal injection of lipopolysaccharide (LPS) or of saline. Three hours after this treatment, all animals were killed and mRNA from brains extracted. Quantitative PCR was performed on 13 selected mRNA species reflecting various aspects of the inflammatory pathway, the melatonin receptor, and a key glycolytic enzyme. An overall trend observed was that the effect of melatonin in modulating LPS-provoked immune responses differed markedly in old and young animals. Melatonin tended to enhance the reaction of younger animals to LPS but suppressed the inflammatory response of older mice. This difference with aging suggests that key immune processes are markedly altered by aging. It is likely that the ability of the immune system to mount a defense is impaired in older animals.
Keywords: Aging, brain, melatonin, gene expression
Current Aging Science
Title: Melatonin Causes Gene Expression in Aged Animals to Respond to Inflammatory Stimuli in a Manner Differing from that of Young Animals
Volume: 1 Issue: 3
Author(s): Edward H. Sharman, Kaizhi G. Sharman and Stephen C. Bondy
Affiliation:
Keywords: Aging, brain, melatonin, gene expression
Abstract: Groups of younger and aged mice were fed either minimal basal diet or the same diet containing 40 ppm melatonin. After 9.3 weeks half of each of these 4 groups of animals received either an intraperitoneal injection of lipopolysaccharide (LPS) or of saline. Three hours after this treatment, all animals were killed and mRNA from brains extracted. Quantitative PCR was performed on 13 selected mRNA species reflecting various aspects of the inflammatory pathway, the melatonin receptor, and a key glycolytic enzyme. An overall trend observed was that the effect of melatonin in modulating LPS-provoked immune responses differed markedly in old and young animals. Melatonin tended to enhance the reaction of younger animals to LPS but suppressed the inflammatory response of older mice. This difference with aging suggests that key immune processes are markedly altered by aging. It is likely that the ability of the immune system to mount a defense is impaired in older animals.
Export Options
About this article
Cite this article as:
Sharman H. Edward, Sharman G. Kaizhi and Bondy C. Stephen, Melatonin Causes Gene Expression in Aged Animals to Respond to Inflammatory Stimuli in a Manner Differing from that of Young Animals, Current Aging Science 2008; 1 (3) . https://dx.doi.org/10.2174/1874609810801030152
DOI https://dx.doi.org/10.2174/1874609810801030152 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dimerization and Ion Binding Properties of S100P Protein
Protein & Peptide Letters Hypertensive Cardiomyopathy in Asymptomatic Patients: A Neglected Diagnosis
Current Hypertension Reviews Editorial [Hot Topic: Why Apoptosis in Pediatric Disorders?]
Current Pediatric Reviews Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1
Current Drug Metabolism An Emerging Antiarrhythmic Target: Late Sodium Current
Current Pharmaceutical Design Sympathetic Nervous System in Patients with Sleep Related Breathing Disorders
Current Hypertension Reviews Population Pharmacogenomics and Personalized Medicine Research in Hungary: Achievements and Lessons Learned
Current Pharmacogenomics and Personalized Medicine New Targeted Therapies for Thyroid Cancer
Current Genomics Role of Vascular Progenitor Cells in Cardiovascular Disease
Current Pharmaceutical Design Chemotherapy and Targeted Agents for Elderly Women with Advanced Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias
Current Cardiology Reviews Impact of Pulmonary Vascular Resistances in Heart Transplantation for Congenital Heart Disease
Current Cardiology Reviews Pleiotropic Effects of Cytokines on Acute Myocardial Infarction: G-CSF as A Novel Therapy for Acute Myocardial Infarction
Current Pharmaceutical Design Role of Iron Deficiency and Overload in the Pathogenesis of Diabetes and Diabetic Complications
Current Medicinal Chemistry Transition of Care for Patients with Diabetes
Current Diabetes Reviews GRK2 Inhibition in Heart Failure: Something Old, Something New
Current Pharmaceutical Design Pharmacokinetic Considerations of Perinatal Antiretroviral Therapy
Current Drug Metabolism The Clinical Problems of Hypertension Treatment in Hemodialysis Patients
Current Vascular Pharmacology Chemistry, Physiology, and Pharmacology of β-Adrenergic Mechanisms in the Heart. Why are β-Blocker Antiarrhythmics Superior?
Current Pharmaceutical Design Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses
Current Pharmaceutical Design